Hypothesis

Aging is not a passive byproduct but an actively maintained kin‑selected kill‑switch. We propose that a conserved extracellular cytokine, IL‑33, is up‑regulated in somatic tissues after reproductive maturity and triggers a caspase‑dependent apoptosis program that removes old individuals, thereby reducing competition for resources with genetically related offspring. This mechanism would be favored when the inclusive fitness benefit of freeing resources for kin outweighs the direct cost of individual death.

Mechanistic Reasoning

• Signal source: IL‑33 is constitutively expressed in barrier tissues (skin, gut) and released upon cellular stress. Recent data show IL‑33 levels rise with age in humans and mice (2).
• Execution pathway: IL‑33 binds its receptor ST2 on neighboring cells, activating NF‑κB and MAPK cascades that converge on the intrinsic apoptosis machinery (Bax/Bak, caspase‑9). Experimental inhibition of ST2 in aged mice delays tissue fibrosis and extends healthspan (4).
• Evolutionary logic: In structured populations with high relatedness (e.g., family groups, colonies), removing a post‑reproductive individual increases the survival probability of kin by Δr·B, where Δr is the relatedness coefficient and B is the resource benefit. When Δr·B > C (cost of lost future reproduction, which is near zero post‑reproduction), selection favors alleles that maintain IL‑33 signaling.

Testable Predictions

1. Genetic manipulation: Knocking out IL‑33 or ST2 specifically in somatic tissues of Drosophila or mice after their reproductive peak will extend lifespan without reducing early‑life fecundity.
2. Kin competition assay: In laboratory populations where individuals are housed with full‑siblings, IL‑33 deficiency will lead to earlier onset of resource‑driven competition (measured by reduced offspring survival) compared with wild‑type controls.
3. Pharmacological blockade: Administration of an anti‑ST2 antibody to aged primates will decrease markers of apoptosis (cleaved caspase‑3) in peripheral tissues and improve frailty scores, while having no effect on young adults.
4. Evolutionary signature: Comparative genomics will show signatures of positive selection on the IL‑33/ST2 locus in species with high kin structure (e.g., eusocial insects, cooperative breeders) but not in solitary species.

Falsifiability

If any of the following observations hold, the hypothesis is refuted:

• IL‑33/ST2 loss‑of‑function fails to increase lifespan in multiple independent model organisms.
• Lifespan extension occurs but is accompanied by a measurable decline in early reproductive output, indicating antagonistic pleiotropy rather than a dedicated kill‑switch.
• Kin‑selection assays show no difference in inclusive fitness between IL‑33‑deficient and wild‑type groups.

By framing aging as an actively maintained, kin‑selected program, this hypothesis redirects longevity medicine from indiscriminate damage repair toward modulating specific signaling pathways that execute the programmed removal of post‑reproductive individuals, offering a precise, evolutionarily informed intervention point.